Edward Sall, MD
Otolaryngic Allergy · Fayetteville, NYNPI 1710961198
Payments from drug & device makers
Across 83 payments — averaging $246.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$20K
- Jazz Pharmaceuticals Inc.$153
- Intersect ENT, Inc.$132
- Alk-abello, Inc$121
- Optinose US, Inc.$117
- Regeneron Healthcare Solutions, Inc.$49
- plus $227 from 8 others
What the payments were for
- Consulting fees$8,10740%
- Speaking & faculty fees$6,60032%
- Travel & lodging$3,11015%
- Food & beverage$2,66113%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 45 | $19,678 |
| Jazz Pharmaceuticals Inc. | 7 | $153 |
| Intersect ENT, Inc. | 3 | $132 |
| Alk-abello, Inc | 7 | $121 |
| Optinose US, Inc. | 7 | $117 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Kowa Pharmaceuticals America, Inc. | 2 | $38 |
| Stryker | 2 | $38 |
| Sanofi | 2 | $35 |
| Merck | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Johnson & Johnson | 1 | $22 |
| Zyla Life Sciences, Inc. | 1 | $20 |
| Smith+Nephew | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$18,523
- RHINAER STYLUS$15,605
- VivAer$150
- RhinAer$150
How this compares
Too few otolaryngic allergy providers in New Yorkto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other otolaryngic allergy in Fayetteville
- Michael ParkerCamillus$55K
- Lawrence KriegerCamillus$2K
- William ReisacherNew York$2K
- Kevin OconnellWarsaw$372
- Dimitry RabkinBrooklyn$102
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.